Exane BNP Paribas analyst Kevin Grundy initiates coverage on Procter & Gamble (NYSE:PG) with a Outperform rating and announces Price Target of $187.
Exane BNP Paribas Initiates Coverage On Procter & Gamble With Outperform Rating, Announces Price Target of $187
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.